Antiviral effects of anti-HBs immunoglobulin and vaccine on HBs antigen seroclearance for chronic hepatitis B infection

scientific article

Antiviral effects of anti-HBs immunoglobulin and vaccine on HBs antigen seroclearance for chronic hepatitis B infection is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00535-016-1189-X
P698PubMed publication ID26943168
P5875ResearchGate publication ID297606873

P50authorMasataka TsugeQ58842302
C Nelson HayesQ87781870
Kazuaki ChayamaQ87781872
Tomokazu KawaokaQ88437730
Hiroshi AikataQ89534368
Michio ImamuraQ90938539
Takashi NakaharaQ92376870
Yoshiiku KawakamiQ114882129
Hidenori OchiQ114899201
Nobuhiko HiragaQ114921454
Atsushi OnoQ118189231
Hiromi KanQ118189235
Grace Naswa MakokhaQ55277932
Daiki MikiQ55965588
P2093author name stringKeiichi Masaki
Eisuke Miyaki
Hiromi Abe-Chayama
Takuro Uchida
Yizhou Zhang
Makokha Grace Naswa
P2860cites workInfusion of hepatitis-B antibody in antigen-positive active chronic hepatitisQ70004003
HBsAg seroclearance in asymptomatic carriers of high endemic areas: appreciably high rates during a long-term follow-upQ80229621
The new front-line in hepatitis B/D research: identification and blocking of a functional receptorQ86077014
Viral hepatitis, type B (MS-2 strain) prevention with specific hepatitis B immune serum globulinQ93711355
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virusQ21128797
Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC).Q33998195
Management of chronic hepatitis B.Q35068048
Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomasQ35598151
Markedly prolonged incubation period of hepatitis B in a chimpanzee passively immunized with a human monoclonal antibody to the a determinant of hepatitis B surface antigenQ36213588
A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzeesQ37410079
Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function.Q37418293
Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.Q38310253
Near completely humanized liver in mice shows human-type metabolic responses to drugsQ38781911
Multiple integration site of hepatitis B virus DNA in hepatocellular carcinoma and chronic active hepatitis tissues from childrenQ40132547
Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis B virusQ40357899
IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosomeQ40679075
Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B.Q42678962
Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B.Q43202400
A randomized controlled trial of pegylated interferon-alpha2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B.Q43208914
Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B.Q43645392
Hepatitis B immune serum globulin in prevention of nonparenterally transmitted hepatitis B.Q44066713
Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B.Q45061899
Histological changes in liver biopsies after one year of lamivudine treatment in patients with chronic hepatitis B infectionQ45121099
Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein.Q45396940
Genetic restriction of immune responsiveness to synthetic peptides corresponding to sequences in the pre-S region of the hepatitis B virus (HBV) envelope geneQ45827803
Modulation of the immunological response to hepatitis B virus by antibodiesQ45831241
The mode of hepatitis B virus DNA integration in chromosomes of human hepatocellular carcinomaQ45842104
Neutralization of hepatitis B virus infectivity by a murine monoclonal antibody: an experimental study in the chimpanzeeQ45848619
Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2bQ46514441
Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.Q46575199
Human hepatitis B vaccine from recombinant yeastQ52850114
Intrahepatic response markers in chronic hepatitis B patients treated with peginterferon alpha-2a and adefovir.Q54373860
Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy.Q54599747
Hepatitis B virus and hepatocellular carcinomaQ58021990
Entecavir treatment for chronic hepatitis B: Adaptation is not needed for the majority of naïve patients with a partial virological responseQ58097652
P433issue11
P921main subjectchronic hepatitis BQ55779876
P304page(s)1073-1080
P577publication date2016-03-04
P1433published inJournal of GastroenterologyQ15764399
P1476titleAntiviral effects of anti-HBs immunoglobulin and vaccine on HBs antigen seroclearance for chronic hepatitis B infection
P478volume51

Reverse relations

cites work (P2860)
Q47557548A mouse model with age-dependent immune response and immune-tolerance for HBV infection
Q41671765A potent human neutralizing antibody Fc-dependently reduces established HBV infections
Q39067120Antibody-dependent and antibody-independent uptake of HBsAg across human leucocyte subsets is similar between individuals with chronic hepatitis B virus infection and healthy donors
Q90681199Human Monoclonal Antibodies as Adjuvant Treatment of Chronic Hepatitis B Virus Infection
Q39101021Research progress of therapeutic vaccines for treating chronic hepatitis B.
Q90681211Toward a Functional Cure for Hepatitis B: The Rationale and Challenges for Therapeutic Targeting of the B Cell Immune Response

Search more.